Terms: = Prostate cancer AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8
11 results:
1. S100A14 inhibits cell growth and epithelial-mesenchymal transition (EMT) in prostate cancer through fat1-mediated Hippo signaling pathway.
Jiang S; Zhu Y; Chen Z; Huang Z; Liu B; Xu Y; Li Z; Lin Z; Li M
Hum Cell; 2021 Jul; 34(4):1215-1226. PubMed ID: 33890248
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive analysis in mucin-producing urothelial-type adenocarcinoma of the prostate: case study with literature review.
Moe K; Maa HC; Pei D; Liang YJ; Chen YL
Pol J Pathol; 2020; 71(3):244-253. PubMed ID: 33112115
[TBL] [Abstract] [Full Text] [Related]
3. Modified York Mason technique for repair of iatrogenic recto-urinary fistula: 20 years of the Montsouris experience.
Bergerat S; Rozet F; Barret E; da Costa JB; Castro A; Dell'oglio P; Galiano M; Ingels A; Salas RS; Cathelineau X
World J Urol; 2018 Jun; 36(6):947-954. PubMed ID: 29442154
[TBL] [Abstract] [Full Text] [Related]
4. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
[TBL] [Abstract] [Full Text] [Related]
5. Validation of the Hospital Episode Statistics Outpatient Dataset in England.
Thorn JC; Turner E; Hounsome L; Walsh E; Donovan JL; Verne J; Neal DE; Hamdy FC; Martin RM; Noble SM
Pharmacoeconomics; 2016 Feb; 34(2):161-8. PubMed ID: 26386702
[TBL] [Abstract] [Full Text] [Related]
6. Synergistic effects of arsenic trioxide combined with ascorbic acid in human osteosarcoma MG-63 cells: a systems biology analysis.
Huang XC; Maimaiti XY; Huang CW; Zhang L; Li ZB; Chen ZG; Gao X; Chen TY
Eur Rev Med Pharmacol Sci; 2014; 18(24):3877-88. PubMed ID: 25555879
[TBL] [Abstract] [Full Text] [Related]
7. Predictive factors for well-being in advanced cancer patients referred for palliative radiotherapy.
Lien K; Zeng L; Zhang L; Nguyen J; Di Giovanni J; Popovic M; Jamani R; Cramarossa G; Culleton S; Chow E
Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):443-51. PubMed ID: 22794326
[TBL] [Abstract] [Full Text] [Related]
8. Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System.
Zeng L; Koo K; Zhang L; Jon F; Dennis K; Holden L; Nguyen J; Tsao M; Barnes E; Danjoux C; Sahgal A; Chow E
Support Care Cancer; 2012 May; 20(5):1037-42. PubMed ID: 21538097
[TBL] [Abstract] [Full Text] [Related]
9. Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3 beta phosphorylation.
Lu Y; Nie D; Witt WT; Chen Q; Shen M; Xie H; Lai L; Dai Y; Zhang J
Mol Cancer Ther; 2008 Oct; 7(10):3203-11. PubMed ID: 18852124
[TBL] [Abstract] [Full Text] [Related]
10. Comparative integromics on fat1, FAT2, FAT3 and FAT4.
Katoh Y; Katoh M
Int J Mol Med; 2006 Sep; 18(3):523-8. PubMed ID: 16865240
[TBL] [Abstract] [Full Text] [Related]
11. 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.
Alibhai SM; Leach M; Tomlinson G; Krahn MD; Fleshner N; Holowaty E; Naglie G
J Natl Cancer Inst; 2005 Oct; 97(20):1525-32. PubMed ID: 16234566
[TBL] [Abstract] [Full Text] [Related]
